Business Context and Reporting Period
Company: Evolution Global Acquisition Corp (EVOX)
Reporting Period: Quarter ended September 30, 2025 (Inception: June 26, 2025)
Status: The Company is a Cayman Islands blank check company (SPAC) formed to effect a business combination. As of the balance sheet date (September 30, 2025), the Company had not commenced operations. The Initial Public Offering (IPO) was consummated subsequently on November 12, 2025.
Key Financial Metrics (As of September 30, 2025)
| Metric | Value |
|---|---|
| Total Assets | $264,878 |
| Total Liabilities | $333,396 |
| Shareholder's Deficit | ($68,518) |
| Net Loss (3 Months Ended Sept 30) | ($72,700) |
| Net Loss (Inception to Sept 30) | ($93,518) |
| Cash and Cash Equivalents | $0 |
| Working Capital Deficit | ($325,070) |
| Debt (Promissory Note - Related Party) | $241,107 |
Material Changes and Subsequent Events
The financial position as of September 30, 2025, reflects a pre-IPO state with no cash and a working capital deficit. Significant changes occurred subsequent to the reporting period:
- IPO Completion: On November 12, 2025, the Company consummated an IPO of 24,000,000 Units at $10.00 per unit, generating gross proceeds of $240,000,000. This included the full exercise of the underwriters' over-allotment option (3,000,000 units).
- Private Placement: Simultaneously, the Company sold 6,800,000 Private Placement Warrants for $6,800,000.
- Liquidity Improvement: Post-IPO, the Company held $240,000,000 in a Trust Account and $1,234,679 in cash outside the trust, resulting in a working capital of $1,180,269.
- Debt Repayment: The outstanding promissory note of $241,107 was repaid in full on November 12, 2025.
- Transaction Costs: Total transaction costs amounted to $15,036,813, including a $9,600,000 deferred underwriting fee.
Outlook, Risks, and Management Commentary
Business Strategy: The Company intends to use proceeds from the IPO and private placement to consummate a business combination with one or more target businesses. It has 24 months from the IPO closing to complete a transaction.
Capital Resources: Management believes the funds held outside the Trust Account ($1.23 million) are sufficient to finance working capital needs for the next 12 months. The Sponsor or affiliates may provide additional working capital loans up to $1,500,000, which may be convertible into warrants.
Risks and Contingencies:
- Going Concern: Prior to the IPO, the Company had no cash and relied on related-party loans. Post-IPO, liquidity is secured by the Trust Account.
- Business Combination Risk: There is no assurance the Company will successfully complete a business combination. If not completed within the 24-month window, the Company will liquidate and distribute Trust Account funds to public shareholders.
- Market Risks: The Company is subject to risks associated with early-stage companies, including economic downturns, geopolitical instability, and changes in regulations.
Investor Verification Checklist
- IPO Closing Confirmation: Verify the final prospectus and Form 8-K filed on November 18, 2025, to confirm the $240 million gross proceeds and full exercise of the over-allotment option.
- Trust Account Status: Confirm the $240 million deposit into the Trust Account and the investment strategy (U.S. government treasury obligations or money market funds).
- Deferred Underwriting Fee: Note the $9.6 million deferred fee payable only upon successful completion of a business combination.
- Founder Shares: Verify the 8,000,000 Class B Founder Shares held by the Sponsor, which represent approximately 25% of the post-IPO equity and are subject to transfer restrictions.
- Warrant Terms: Review the exercise price of $11.50 per share for both Public and Private Placement Warrants and the redemption triggers (e.g., $18.00 per share threshold).